Concerns in the SESAMI Trial

In a clinical trial aiming to evaluate the safety and effectiveness of drug-eluting stents in comparison with bare-metal stents (BMS) in acute myocardial infarction (AMI), the description of the end points should be clear and identical. As an important composite clinical end point, major adverse